Suppr超能文献

[内异停方通过TREM1/TLR4/NF-κB信号通路抑制巨噬细胞M1极化预防子宫内膜异位症术后复发的机制]

[Mechanisms of Neiyiting Decoction in Preventing Postoperative Recurrence of Endometriosis by Inhibiting Macrophage M1 Polarization Through the TREM1/TLR4/NF-κB Signaling Pathway].

作者信息

Lu Lijuan, Zeng Weiwei, Wang Jingwen, Zhang Lurong, Liu Ying, Sun Xueliang, Xu Wen, Fang Xiaohui, Yan Yichao, Xia Qinhua

机构信息

( 215007) Department of Gynecology, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215007, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):371-381. doi: 10.12182/20250360601.

Abstract

OBJECTIVE

The high post-surgery recurrence rate of endometriosis (EMs) has emerged as a challenge in the long-term manaagement of the condition. This study is aimed at investigating the mechanisms of Neiyiting (NYT) decoction in preventing postoperative recurrence of EMs.

METHODS

An animal model of EMs postoperative recurrence and a model of endometrial stromal cells (hEM15A) cocultured with macrophages (RAW 264.7 cell line) were established for both and experiments. An autotransplantation method was used to establish a rat model of EMs. The rats were divided into 4 groups (6 rats per group) and received the corresponding treatments: a Model group receiving distilled water, a Gestrinone group receiving gestrinone at 0.325 mg/kg, a low-dose NYT (NYT-L) group receiving NYT decoction at 5.04 g/(kg·d), and a high-dose NYT (NYT-H) group receiving NYT decoction at 10.08 g/(kg·d). The treatment was administered for 3 weeks via intragastric gavage. In addition, 6 SD rats were randomly selected for the control group (Control group), and were given distilled water for 3 weeks via intragastric gavage. The sizes and pathological changes of recurrent lesions in EMs rats were observed. Immunohistochemistry and qRT-PCR were performed to assess the expression of M1 macrophage marker CD86 protein and mRNA . Additionally, immunohistochemistry and qRT-PCR were used to assess the expression of indicator proteins related to the triggering receptor expressed on myeloid cells 1 (TREM1)/Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway and mRNA. The proliferation of hEM15A cells in the coculture experiment was observed. Flow cytometry was performed to determine the polarization of RAW264.7 macrophages, and qRT-PCR was used to determine the expression levels of inducible nitric oxide synthase () and interleukin 1β () mRNA. Western blot was performed to determine the expression of signaling pathway-related indicator proteins . ELISA was performed to determine the levels of inflammatory factors .

RESULTS

Compared with the Model group, the volume of recurrent lesions in the NYT-H group was reduced ( < 0.01). Findings from the macrophage M1 polarization assessment showed that the expression levels of CD86 protein and mRNA in the recurrent lesions of the Model group were higher than those in the control group ( < 0.01). The expression levels of CD86 protein and mRNA in the recurrent lesions of the NYT-H group were lower than those of the Model group ( < 0.01). In addition, the RAW 264.7 cell experiment further verified that NYT decoction could reduce the number of CD86-positive macrophages induced by plasmids overexpressing TREM1 and reduce the expression of and mRNA ( < 0.01). The results of the hEM15A cell proliferation assay showed that NYT decoction down-regulated KI-67 protein expression in hEM15A cells induced by macrophage M1 polarization ( < 0.01). The results of TREM1/TLR4/NF-κB signaling pathway showed that the protein and mRNA expression levels of TREM1, TLR4, and NF-κB in the recurrent lesions of the Model group were higher than those of the control group ( < 0.01). Compared with those in the Model group, the protein and mRNA expression levels of TREM1, TLR4, and NF-κB in the recurrent lesions of the NYT-H group were lower ( < 0.01). In addition, the coculture experiment of RAW264.7 and hEM15A cells further confirmed that NYT decoction reduced the expression of TREM1, TLR4, and P-P65 proteins ( < 0.01).

CONCLUSION

NYT decoction can inhibit macrophage M1 polarization through the TREM1/TLR4/NF-κB signaling pathway, improve the inflammation level, and inhibit the formation of ectopic endometrial lesions, thereby preventing postoperative recurrence of EMs.

摘要

目的

子宫内膜异位症(EMs)术后高复发率已成为该疾病长期管理中的一项挑战。本研究旨在探讨内异停(NYT)汤预防EMs术后复发的机制。

方法

建立EMs术后复发动物模型以及子宫内膜基质细胞(hEM15A)与巨噬细胞(RAW 264.7细胞系)共培养模型用于体内和体外实验。采用自体移植法建立大鼠EMs模型。将大鼠分为4组(每组6只)并给予相应处理:模型组给予蒸馏水,孕三烯酮组给予0.325 mg/kg孕三烯酮,低剂量NYT(NYT-L)组给予5.04 g/(kg·d) NYT汤,高剂量NYT(NYT-H)组给予10.08 g/(kg·d) NYT汤。通过灌胃给药3周。此外,随机选取6只SD大鼠作为对照组,通过灌胃给予蒸馏水3周。观察EMs大鼠复发病灶的大小和病理变化。采用免疫组织化学和qRT-PCR评估M1巨噬细胞标志物CD86蛋白和mRNA的表达。另外,采用免疫组织化学和qRT-PCR评估与髓系细胞触发受体1(TREM1)/Toll样受体4(TLR4)/核因子κB(NF-κB)信号通路相关的指标蛋白及其mRNA的表达。观察共培养实验中hEM15A细胞的增殖情况。采用流式细胞术检测RAW264.7巨噬细胞的极化情况,并用qRT-PCR检测诱导型一氧化氮合酶()和白细胞介素1β()mRNA的表达水平。采用蛋白质印迹法检测信号通路相关指标蛋白的表达。采用酶联免疫吸附测定法检测炎症因子水平。

结果

与模型组相比,NYT-H组复发病灶体积减小(<0.01)。巨噬细胞M1极化评估结果显示,模型组复发病灶中CD86蛋白和mRNA表达水平高于对照组(<0.01)。NYT-H组复发病灶中CD86蛋白和mRNA表达水平低于模型组(<0.01)。此外,RAW 264.7细胞实验进一步证实,NYT汤可减少过表达TREM1质粒诱导的CD86阳性巨噬细胞数量,并降低和mRNA的表达(<0.01)。hEM15A细胞增殖实验结果显示,NYT汤可下调巨噬细胞M1极化诱导的hEM15A细胞中KI-67蛋白表达(<0.01)。TREM1/TLR4/NF-κB信号通路结果显示,模型组复发病灶中TREM1、TLR4和NF-κB的蛋白及mRNA表达水平高于对照组(<0.01)。与模型组相比,NYT-H组复发病灶中TREM1、TLR4和NF-κB的蛋白及mRNA表达水平较低(<0.01)。此外,RAW264.7与hEM15A细胞共培养实验进一步证实,NYT汤可降低TREM1、TLR4和P-P65蛋白的表达(<0.01)。

结论

NYT汤可通过TREM1/TLR4/NF-κB信号通路抑制巨噬细胞M1极化,改善炎症水平,抑制异位子宫内膜病灶形成,从而预防EMs术后复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95de/12207022/47269c146c07/scdxxbyxb-56-2-371-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验